insights_auto
Why is DRREDDY up २.७१%?
Dive Deeperchevron_right
DRREDDY:NSE
डक्टर रेड्डीज
₹ १,२२९.४०
arrow_upward
+२.७१%(+३२.४०) 1D
अक्टोबर १२, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRREDDY...
Open
₹ १,१९७.००
High
₹ १,२३५.००
Low
₹ १,१९६.९०
Mkt. cap
१०.२४ खरब
Avg. vol.
१७.९५ लाख
Volume
१७.५७ लाख
Dividend
०.६५%
Quarterly dividend
₹ २.००
Ex-dividend date
२०२६ जुलाई १०
P/E ratio
३१.७९
52-wk high
₹ १,४१४.९०
52-wk low
₹ १,१०१.००
EPS
₹ ३८.६७
Shares outstanding
१६.६१ करोड
No. of employees
२८ हजार
Open
₹ १,१९७.००
High
₹ १,२३५.००
Low
₹ १,१९६.९०
Mkt. cap
१०.२४ खरब
Avg. vol.
१७.९५ लाख
Volume
१७.५७ लाख
Dividend
०.६५%
Quarterly dividend
₹ २.००
Ex-dividend date
२०२६ जुलाई १०
P/E ratio
३१.७९
52-wk high
₹ १,४१४.९०
52-wk low
₹ १,१०१.००
EPS
₹ ३८.६७
Shares outstanding
१६.६१ करोड
No. of employees
२८ हजार
News stories
From web sources and news partners
CNBC
·
३२ मिनेट पहिले
The bull market turned 4 years old on Monday. Investors say reaching a fifth birthday could be challenging
The Business Journals
·
३१ मिनेट पहिले
FirstBank CEO rings NYSE bell a decade after IPO as lender eyes future
Yahoo Finance
·
५ घण्टा पहिले
A handful of tech stocks are masking an ugly S&P 500 problem
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
About डक्टर रेड्डीज
CEOErez Israeli
Employees२७.५ हजार
Founded१९८४
Headquartersहैदराबाद, आन्ध्र प्रदेश, भारत
Sector-
Websitedrreddys.com